Clinical Characteristics and Prognostic Value of Ro52/SSA Antibodies in Idiopathic Inflammatory Myopathies

Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis

(2022) Edward K. L. Chan   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Coexisting of anti-Ro52 autoantibodies on anti-MDA5 autoantibodies-positive dermatomyositis is highly associated with rapidly progressive interstitial lung disease and mortality risk

(2022) Chengyin Lv et al.   JOURNAL OF RHEUMATOLOGY

The Impact of Dysphagia in Myositis: A Systematic Review and Meta-Analysis

(2020) Bendix Labeit et al.   Journal of Clinical Medicine

Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis

(2020) Xiaojing Xing et al.   RESPIRATORY MEDICINE

Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease

(2020) Antao Xu et al.   RHEUMATOLOGY

Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays

(2019) Jan Damoiseaux et al.   AUTOIMMUNITY REVIEWS

Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies

(2017) Jingli Shi et al.   JOURNAL OF RHEUMATOLOGY

Short-Term and Long-Term Outcome of Anti-Jo1-Positive Patients with Anti-Ro52 Antibody

(2011) Isabelle Marie et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Diagnostic utility of anti-Ro52 detection in systemic autoimmunity

(2010) M. Dugar et al.   POSTGRADUATE MEDICAL JOURNAL

Latest update on the Ro/SS-A autoantibody system

(2009) J. Schulte-Pelkum et al.   AUTOIMMUNITY REVIEWS